To evaluate the effectiveness and safety of different pharmacological interventions to treat chemotherapy induced diarrhoea in patients with colorectal cancer.
This is a protocol.
Interventions for reducing diarrhoea in patients receiving chemotherapy for colorectal cancer
You may also be interested in:
- The addition of bevacizumab to chemotherapy of metastatic colorectal cancer prolongs both progression-free survival as well as overall survival in first- and second line therapy.
- Epidermal growth factor receptor (EGFR) inhibitors for metastatic colorectal cancer
- Chemotherapy improves the survival of people with advanced colorectal cancer, but the adverse effects and impact on quality of life are not yet known.
- Radioactive beads given in addition to chemotherapy does not improve control of cancer nor survival in patients with colorectal cancer and metastasis in the liver.
- Chemotherapy with platinum compounds for metastatic colorectal cancer